In adults with metabolic syndrome, metformin lowered the risk of developing type 2 diabetes but didn’t prevent cancer, cardiovascular disease, or death. In another trial involving older adults with age-related muscle loss, metformin didn’t improve physical performance.
Similar Posts
Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks – MedCity News
It’s not uncommon for a patient, when searching their insurer’s provider directory, to find listings for…
How To Stop An Online Shopping Habit In 8 Expert-Backed Steps
In 2023, Americans spent a record average of $3.4 billion per day shopping online and a…
Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D
Checkpoint inhibitors transformed cancer treatment, bringing to patients immunotherapies now widely used to treat a range…
Skin Care & Facial Massage Tips From A Facialist Called “The Queen Of Skin”
If I’m going to get skin care advice, I might as well get it from someone…
Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK
Medbridge, a digital care company, launched new AI-powered motion-capture capabilities on Thursday through its digital musculoskeletal…
Frozen Peanut Butter Banana Split Cups
I put a classic Fit Foodie spin on the viral banana bark from years past, and…
